[Effects of oral administration of subcontinuous doses of delayed-action isosorbide-5-mononitrate. Absence of tolerance].
作者信息
Lai C, Onnis E, Orani E, Soro A, Pirisi R, Cherchi A
出版信息
Cardiologia. 1988 Nov;33(11):1069-74.
PMID:3076514
Abstract
摘要
相似文献
1
[Effects of oral administration of subcontinuous doses of delayed-action isosorbide-5-mononitrate. Absence of tolerance].[口服亚持续剂量缓释5-单硝酸异山梨酯的效果。无耐受性]
Cardiologia. 1988 Nov;33(11):1069-74.
2
Is isosorbide mononitrate better than the dinitrate?
Drug Ther Bull. 1984 Jan 27;22(2):7-8.
3
4
[Anti-angina action and tolerance of isosorbide-5-mononitrate or nifedipine in retard form].
Z Kardiol. 1986;75 Suppl 3:112-4.
5
6
Extended-release isosorbide mononitrate for angina.
Med Lett Drugs Ther. 1994 Feb 4;36(915):13-4.
7
[Intraindividual dose-response relationship of sustained-release Elantan].[缓释伊坦坦的个体内剂量-反应关系]
Z Kardiol. 1986;75 Suppl 3:77-9.
8
Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.5-单硝酸异山梨酯控释制剂与传统硝酸异山梨酯对稳定型心绞痛男性运动能力影响的比较。
Am J Cardiol. 1990 Jun 1;65(20):1308-12. doi: 10.1016/0002-9149(90)91318-z.
9
10
Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.
Drugs. 1987;33 Suppl 4:111-7. doi: 10.2165/00003495-198700334-00020.
Zotero 插件